RxDoctor Payments Data

Diane Highum

Psychiatry · Costa Mesa, CANPI 1396868386

Payments from drug & device makers

What this record shows

That places this record below the midpoint for psychiatry clinicians in CA, where the typical reported total is $186.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$8,781,376in research payments, 2019–2025

Across 1,102 payments — averaging $7968.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$2.2M
  • AbbVie$1.8M
  • Teva Pharmaceuticals USA, Inc.$1.2M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.1M
  • Hoffmann-la Roche Limited$630K
  • Merck$542K
  • plus $1.3M from 16 others

How this compares

$0 in reported general payments places this provider in the 10th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Other psychiatry in Costa Mesa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →